Posted 01 July 2021 | By Kari Oakes The US Food and Drug Administration has issued new draft guidance for clinical trials examining the adhesion performance of transdermal and topical delivery systems (collectively, TDS) for new drug applications. Surface area is an important variable in determining the amount of drug delivered through a TDS; adhesion performance can affect...
